UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Diagnosis, treatment and supportive management of chronic lymphocytic leukemia: recommendations of the Dutch HOVON CLL working group

Leukemia & lymphoma, 2022-08, Vol.63 (10), p.2276-2289

2022

Volltextzugriff (PDF)

Treatment options in massive pulmonary embolism during pregnancy; A case-report and review of literature

Thrombosis research, 2009-05, Vol.124 (1), p.1-5

2009

Volltextzugriff (PDF)

The evolving landscape of COVID‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL

American journal of hematology, 2023-12, Vol.98 (12), p.1856-1868

2023

Volltextzugriff (PDF)

Use of the CD19 count in a primary care laboratory as a screening method for B-cell chronic lymphoproliferative disorders in asymptomatic patients with lymphocytosis

Clinical chemistry and laboratory medicine, 2011-01, Vol.49 (1), p.115-120

2011

Volltextzugriff (PDF)

P1523: IMMUNOGENICITY OF THE 13‐VALENT PNEUMOCOCCAL CONJUGATED VACCINE FOLLOWED BY THE 23‐VALENT POLYSACCHARIDE VACCINE IN CHRONIC LYMPHOCYTIC LEUKEMIA

HemaSphere, 2023-08, Vol.7 (S3), p.e8157636-n/a

2023

Volltextzugriff (PDF)

DNA damage–induced transcriptional program in CLL: biological and diagnostic implications for functional p53 testing

Blood, 2011-02, Vol.117 (5), p.1622-1632

2011

Volltextzugriff (PDF)

Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia

Vaccines (Basel), 2023-07, Vol.11 (7), p.1201

2023

Volltextzugriff (PDF)

Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: A multicenter phase 2 study

Leukemia research, 2014-01, Vol.38 (1), p.34-41

2014

Volltextzugriff (PDF)

Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemia

British journal of haematology, 2013-11, Vol.163 (4), p.496-500

2013

Volltextzugriff (PDF)

CMV-specific CD8+ T-cell function is not impaired in chronic lymphocytic leukemia

Blood, 2014-01, Vol.123 (5), p.717-724

2014

Volltextzugriff (PDF)

Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC‐wide approach

British journal of haematology, 2014-11, Vol.167 (4), p.565-569

2014

Volltextzugriff (PDF)

Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia

Leukemia & lymphoma, 2013-08, Vol.54 (8), p.1849-1853

2013

Volltextzugriff (PDF)

First-Line Treatment and Outcome of T-Cell Prolymphocytic Leukemia in the Netherlands; A Nationwide Population-Based Study

Blood, 2022-11, Vol.140 (Supplement 1), p.3788-3789

2022

Volltextzugriff (PDF)

Immunogenicity of the Currently Recommended Pneumococcal Vaccination Schedule in Patients with Chronic Lymphocytic Leukaemia

Blood, 2022-11, Vol.140 (Supplement 1), p.7020-7022

2022

Volltextzugriff (PDF)

Chronic lymphocytic leukemia specific T-cell subset alterations are clone-size dependent and not present in monoclonal B lymphocytosis

Leukemia & lymphoma, 2012-11, Vol.53 (11), p.2321-2325

2012

Volltextzugriff (PDF)

Thrombotic and Bleeding Complications in Patients with Chronic Lymphocytic Leukemia and Severe COVID-19: A Study of Eric, the European Research Initiative on CLL

Blood, 2022-11, Vol.140 (Supplement 1), p.2772-2775

2022

Volltextzugriff (PDF)

Differences in Clinical Course and Management of Sars-CoV2 Infection in Patients with Chronic Lymphocytic Leukemia between the Sequential Pandemic Phases: An Eric Study

Blood, 2022-11, Vol.140 (Supplement 1), p.2333-2337

2022

Volltextzugriff (PDF)

Exome-Wide Sequencing Reveals Oncogenic Mutations in Both Progressive and Non-Progressive MBL

Blood, 2015-12, Vol.126 (23), p.361-361

2015

Volltextzugriff (PDF)

Patients with Chronic Lymphocytic Leukemia Belonging to the B-Cell Receptor Stereotypy Subset #2 Have Long Progression Free Survival after Chemo- or Chemoimmunotherapy in the HOVON68 Trial

Blood, 2017-12, Vol.130, p.4312-4312

2017

Volltextzugriff (PDF)

Assessment of p53 and ATM Functionality in Chronic Lymphocytic Leukemia By Multiplex Ligation-Dependent Probe Amplification

Blood, 2015-12, Vol.126 (23), p.2918-2918

2015

Volltextzugriff (PDF)

The Impact Of Subclonal Versus Clonal Novel Recurrent Mutations On Treatment Outcome In Previously Untreated High Risk CLL Patients: Results From The HOVON68 Trial

Blood, 2013-11, Vol.122 (21), p.2861-2861

2013

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)
Japanisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diagnosis, treatment and supportive management of chronic lymphocytic leukemia: recommendations of the Dutch HOVON CLL working group

Treatment options in massive pulmonary embolism during pregnancy; A case-report and review of literature

The evolving landscape of COVID‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL

Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia

Use of the CD19 count in a primary care laboratory as a screening method for B-cell chronic lymphoproliferative disorders in asymptomatic patients with lymphocytosis

P1523: IMMUNOGENICITY OF THE 13‐VALENT PNEUMOCOCCAL CONJUGATED VACCINE FOLLOWED BY THE 23‐VALENT POLYSACCHARIDE VACCINE IN CHRONIC LYMPHOCYTIC LEUKEMIA

DNA damage–induced transcriptional program in CLL: biological and diagnostic implications for functional p53 testing

Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia

P619: TRACKING DISEASE PARAMETERS BY MRD, CT AND PET IN FIRST LINE CLL PATIENTS TREATED WITH FIXED DURATION IBRUTINIB‐VENETOCLAX; INTERIM ANALYSIS OF THE FIRST 30 PATIENTS IN HOVON 158/NEXT STEP TRIAL

Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: A multicenter phase 2 study

Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemia

CMV-specific CD8+ T-cell function is not impaired in chronic lymphocytic leukemia

Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study

Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC‐wide approach

Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia

First-Line Treatment and Outcome of T-Cell Prolymphocytic Leukemia in the Netherlands; A Nationwide Population-Based Study

Immunogenicity of the Currently Recommended Pneumococcal Vaccination Schedule in Patients with Chronic Lymphocytic Leukaemia

Chronic lymphocytic leukemia specific T-cell subset alterations are clone-size dependent and not present in monoclonal B lymphocytosis

Exploratory Results of PET-CT and Residual Lymph Node Fine Needle Aspiration of Patients Treated with First-Line Venetoclax and Ibrutinib for CLL/Sll; First Interim Analysis of the Phase 2 HOVON 158/Next STEP Trial

Thrombotic and Bleeding Complications in Patients with Chronic Lymphocytic Leukemia and Severe COVID-19: A Study of Eric, the European Research Initiative on CLL

Differences in Clinical Course and Management of Sars-CoV2 Infection in Patients with Chronic Lymphocytic Leukemia between the Sequential Pandemic Phases: An Eric Study

Exome-Wide Sequencing Reveals Oncogenic Mutations in Both Progressive and Non-Progressive MBL

Patients with Chronic Lymphocytic Leukemia Belonging to the B-Cell Receptor Stereotypy Subset #2 Have Long Progression Free Survival after Chemo- or Chemoimmunotherapy in the HOVON68 Trial

Assessment of p53 and ATM Functionality in Chronic Lymphocytic Leukemia By Multiplex Ligation-Dependent Probe Amplification

The Impact Of Subclonal Versus Clonal Novel Recurrent Mutations On Treatment Outcome In Previously Untreated High Risk CLL Patients: Results From The HOVON68 Trial

Suchergebnisse filtern